This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis B, Hepatitis C, HIV or HIV Infections
and you are
between 18 and 39
years old
-
The phase for this study is not defined.
Show me locations

The purpose

In this study, researchers from UCLA and Friends Community Center will work together in designing a program to assist young homeless stimulant-using gay and bisexual homeless men to complete the hepatitis vaccine and in reducing drug and sexual activity. Using nurse case management strategies, found successful with homeless adults as well as contingency management strategies, found successful with gay and bisexual homeless adults by the community partners, the investigators will evaluate the effectiveness of a program that combines both strategies. As stimulant use threatens to increase homeless persons' risk of exposure to hepatitis A and B viruses, particularly among young users who may not yet be HBV-infected, this research is targeted to engage this group in treatment, until they are suitably protected from HBV, and hopefully reduce risk for HCV and HIV as well.

Provided treatments

  • Behavioral: NCMIT
  • Behavioral: SCMIT
Tris trial is registered with FDA with number: NCT00926146. The sponsor of the trial is University of California, Los Angeles and it is looking for 451 volunteers for the current phase.
Official trial title:
HBV Prevention for Homeless at Risk for HBV/HCV/HIV